RT Journal Article
T1 Macular Thickness as a Potential Biomarker of Mild Alzheimer's Disease
A1 García Martín, Elena Salobrar
A1 Rojas López, Blanca
A1 Ramírez Sebastián, Ana Isabel
A1 Hoz Montañana, Rosa de
A1 Salazar Corral, Juan José
A1 Yubero Pancorbo, Raquel
A1 Gil, Pedro
A1 Triviño Casado, Alberto
A1 Ramirez Sebastian, Jose Manuel
AB Although several postmortem findings in the retina of patients with Alzheimer's disease (AD) are available, new biomarkers for early diagnosis and follow-up of AD are still lacking. It has been postulated that the defects in the retinal nerve fiber layer (RNFL) may be the earliest sign of AD, even before damage to the hippocampal region that affects memory. This fact may reflect retinal neuronal-ganglion cell death and axonal loss in the optic nerve in addition to aging.
PB Elsevier / American Academy of Ophthalmology
SN 0161-6420
YR 2014
FD 2014-03-18
LK https://hdl.handle.net/20.500.14352/35304
UL https://hdl.handle.net/20.500.14352/35304
LA eng
NO 1. Hinton DR, Sadun AA, Blanks JC, et al. Optic-nerve degeneration in Alzheimer’s disease. N Engl J Med 1986;315:485–7.2. He XF, Liu YT, Peng C, et al. Optical coherence tomography assessed retinal nerve fiber layer thickness in patients with Alzheimer’s disease: a meta-analysis. Int J Ophthalmol 2012;5:401–5.3. Blanks JC, Torigoe Y, Hinton DR, et al. Retinal pathology in Alzheimer’s disease. I. ganglion cell loss in foveal/parafoveal retina. Neurobiol Aging 1996;17:377–84.4. Tzekov RT, Mullan M. Vision function abnormalities in alzheimer’s disease. Surv Ophthalmol 2013; In press: http://dx.doi.org/10.1016/j.survophthal.2013.10.002.5. Koronyo Y, Salumbides BC, Black KL, et al. Alzheimer’s disease in the retina: Imaging retinal ab plaques for early diagnosis and therapy assessment. Neurodeg Dis 2012;10:285–93.
NO Ministerio de Ciencia e Innovación (MICINN)
NO Redes temáticas de investigación cooperativa en  salud (RETICs)
DS Docta Complutense
RD 30 abr 2024